3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
8
Recruiting
5
Active not recruiting
4
Unknown
2
Terminated
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pancreatic Neoplasms
8
Esophageal Squamous Cell Carcinoma
6
Carcinoma, Non-Small-Cell Lung
6
Triple Negative Breast Neoplasms
3
Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Uterine Cervical Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Squamous NSCLC
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Salivary Gland Malignant Neoplasms
1
Pancreatic cancer, adult
1
Pancreatic Cancer Resectable
1
Melanoma
1
Mediastinal Neoplasms
1
Locally Advanced Non-Small Cell Lung Cancer
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Carcinoma
1
Brain Neoplasms
1
Anophthalmia with pulmonary hypoplasia
1
Advanced Triple Negative Breast Cancer
1
Advanced Non-squamous Non-small-cell Lung Cancer
1
Advan'ce'd
1
Interventions
Cisplatin
9
Radiotherapy
6
Carboplatin
6
toripalimab
5
pembrolizumab
5
Surgical Procedures, Operative
5
Nivolumab
5
Docetaxel
5
Cetuximab
5
Paclitaxel
4
Drug Therapy
4
Taxes
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
trilaciclib
2
tislelizumab
2
nimotuzumab
2
camrelizumab
2
Radiotherapy, Intensity-Modulated
2
Injections
2
Cyclophosphamide
2
Blood Specimen Collection
2
spartalizumab
1
penpulimab
1
fludarabine phosphate
1
fludarabine
1
dexamethasone-(C21-phosphoramide)-(anti-EGFR)
1
dalpiciclib
1
anlotinib
1
Tea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Squamous Cell Carcinoma of Head and Neck
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT06728618
2024-12-11
OSCC
Shanghai Zhongshan Hospital
Phase 2
Not yet recruiting
28 enrolled